Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation
about
The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial FibrillationEvaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Association between left atrial low-voltage area, serum apoptosis, and fibrosis biomarkers and incidence of silent cerebral events after catheter ablation of atrial fibrillation.EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Role of magnetic resonance imaging in atrial fibrillation ablationCardiovascular magnetic resonance: applications in daily practice.The use of cardiac magnetic resonance imaging in the diagnostic workup and treatment of atrial fibrillation.Velocity encoded cardiovascular magnetic resonance to assess left atrial appendage emptying.Quantitative assessment of atrial regional function using motion estimation computed tomography.Quantitative tissue-tracking cardiac magnetic resonance (CMR) of left atrial deformation and the risk of stroke in patients with atrial fibrillation.Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS)Quantitative Imaging of Preamyloid Oligomers, a Novel Structural Abnormality, in Human Atrial SamplesHypertension is associated with preamyloid oligomers in human atrium: a missing link in atrial pathophysiology?Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.Age and CHADS2 Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial FibrillationComputational Shape Models Characterize Shape Change of the Left Atrium in Atrial Fibrillation.Dynamic inversion time for improved 3D late gadolinium enhancement imaging in patients with atrial fibrillationRapid automatic segmentation of abnormal tissue in late gadolinium enhancement cardiovascular magnetic resonance images for improved management of long-standing persistent atrial fibrillation.Cardiac magnetic resonance imaging: a new tool to identify cardioaortic sources in ischaemic stroke.Accelerated late gadolinium enhancement cardiac MR imaging with isotropic spatial resolution using compressed sensing: initial experience.Interatrial septal thickness as a marker of structural and functional remodeling of the left atrium in patients with atrial fibrillation.Stroke in Atrial Fibrillation - Long-term Follow-up of Cardiovascular Events.Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study.Stroke Risk Predictor Scoring Systems in Atrial Fibrillation.Cardiac magnetic resonance T1 mapping of left atrial myocardium.Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation.IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial.Adverse Outcomes from Atrial Fibrillation;Mechanisms, Risks, and Insights Learned from Therapeutic Options.Exploring the Potential Role of Catheter Ablation in Patients with Asymptomatic Atrial Fibrillation: Should We Move away from Symptom Relief?Association of Left Atrial Fibrosis Detected by Delayed Enhancement Magnetic Resonance Imaging and Risk of Stroke in Patients with Atrial Fibrillation.Functional Remodeling of Both Atria is Associated with Occurrence of Stroke in Patients with Paroxysmal and Persistent Atrial FibrillationAtrial fibrosis: a risk stratifier for atrial fibrillation.Emerging concepts for myocardial late gadolinium enhancement MRI.Cardiac magnetic resonance for prognostic assessment: present applications and future directions.Assessment and impact of cardiac fibrosis on atrial fibrillation.Left atrium and the imaging of atrial fibrosis: catch it if you can!Cardiac MRI: a central prognostic tool in myocardial fibrosis.CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation.Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications.
P2860
Q26747263-E7885C27-920D-49A4-9740-6983B84D0158Q26799163-85098939-C422-4501-B5CB-37AAFAAA95FFQ27341873-D3A4B665-E85B-459E-829B-AF46A8E44747Q30316481-E9398F83-35AB-4AB8-8F79-C259F5967328Q30375302-A14CCBF9-8D5D-4B3E-A056-9B330C0DABA3Q30410162-A5D9274F-CF73-482A-BB69-681A2EAB44A6Q30430740-CCFF3A31-0428-4936-93E1-B4BB37A8DA1BQ30459988-59FD8DC3-DBF8-44B6-A4D9-23B3B7B5D307Q30463868-DF8A2976-E3D5-4867-A04E-1ABFA14D33E9Q30587145-D9388DCA-ED89-4165-978E-4FE659B39BF4Q30665286-2753C663-D6DD-44C9-9872-8C880B828B2AQ33765348-6F24DA2C-4794-4B3E-857A-FC0B1663191AQ33810841-F9230EAE-71AF-4E9F-9F34-0CA2D686AC8EQ35115100-FBC1BCAA-970A-44FA-B73F-06396DCCB1F8Q35228412-54F2E555-1C3C-4169-B307-D8D03CB310D2Q35764897-C0BDDC3C-B8D6-4F9A-A800-FD4EBD11F68BQ36025007-33A48E41-F2A5-4133-88D5-9CCB1AA2C3B9Q36035757-490A083C-BB54-4934-91AE-847D3FB4F743Q36131461-1078C762-3BA7-47BD-B3AE-7B8C5FA6318DQ36142058-D9C61020-E76A-4D50-A2DC-0FDDF521AE80Q36186641-5EE9EC73-6F63-4741-8254-4736DB91695BQ36272079-3038EE04-872C-4C96-952C-C0D1C1EF284FQ36458873-6DC90599-1445-4FFB-AE2D-84E47679EAAEQ37072178-A1241DAB-0DA1-4440-ABC3-3FBA092D0B2AQ37115147-E342B50E-4820-4755-8D7E-AC743AB4FAD7Q37131859-ADA2FFE8-E4F8-4E45-83F9-0524E1DAB8F7Q37281768-B5B6EBDC-708E-477C-B0B3-A764EB09D7E9Q37355944-5AE57A6D-743C-443B-A7BD-517059572BF5Q37495633-B9ACBB1A-AE0A-4239-8E9A-D39C3BB473A3Q37495738-722AB822-1238-430F-BA8B-94AC437EA352Q37495760-BD0AF718-0972-45DE-992C-68C87F0EB278Q37590770-87345B3F-4398-4CBA-B01D-BA714FD0E13EQ38081151-E9AF39E9-B52C-451A-B067-2168E6136C00Q38126089-CC690F57-0B4F-4C16-AC0F-B23E2A9E9EBBQ38206247-86526429-AE0E-46CA-8E28-1A31184E42F7Q38221966-59CFBAFB-3686-4F4D-A269-39F0E60C6D4CQ38234439-0A1CC7D8-FDC9-448E-84EB-FA6CBF6122A2Q38263089-C46F750C-A278-4D48-8686-BBBF28850DFCQ38372615-2E8F9CE2-C491-4067-9977-889CF86307C0Q38636457-D69346C7-2D09-43B5-B34A-9996A98200D9
P2860
Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Association of left atrial fib ...... ients with atrial fibrillation
@ast
Association of left atrial fib ...... ients with atrial fibrillation
@en
type
label
Association of left atrial fib ...... ients with atrial fibrillation
@ast
Association of left atrial fib ...... ients with atrial fibrillation
@en
prefLabel
Association of left atrial fib ...... ients with atrial fibrillation
@ast
Association of left atrial fib ...... ients with atrial fibrillation
@en
P2093
P2860
P1476
Association of left atrial fib ...... ients with atrial fibrillation
@en
P2093
Christian Mahnkopf
Christopher J McGann
Dennis Parker
Eugene Kholmovski
Gaston Vergara
Johannes Brachmann
Marcos Daccarett
Nassir F Marrouche
Nathan S Burgon
Nazem Akoum
P2860
P304
P356
10.1016/J.JACC.2010.09.049
P407
P577
2011-02-01T00:00:00Z